Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $11.72 and last traded at $11.72, with a volume of 1339 shares changing hands. The stock had previously closed at $9.9850.
Oxford BioMedica Stock Performance
The business’s 50-day moving average price is $8.75 and its 200 day moving average price is $7.56. The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.67 and a current ratio of 1.89.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Further Reading
- Five stocks we like better than Oxford BioMedica
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
